Shukra Pharmaceuticals logo

Shukra Pharmaceuticals financials and balance sheet

NSE: SHUKRAPHARBSE: 524632Pharmaceuticals & BiotechnologySmall Cap

Last close ₹64.46up ₹1.93 (3.09%)BSE ₹64.58

Share price at the NSE close on 23 Oct 2026. Previous close ₹62.53.

52-week range of BSE trades to 23 Oct 2026
₹26.30Low, 27 May 2026₹75.50High, 6 Oct 2026
Market cap
₹2,834 Cr1,258th largest listed
P/E
78.6
P/B
31.5
Dividend yield
0.02%
ROE
47.2%
ROCE
47.3%
Debt to equity
0.06
Volume, NSE
1,99,54,06817.8% delivered

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Shukra Pharmaceuticals annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings

Operating and net margin, per cent

  • Operating margin
  • Net margin

The years either side of a change of basis do not compare. From the year to Mar 2020, the company's revenue for that year, ₹12 Cr, differs from its quarters added, ₹10 Cr. From the year to Mar 2022, the company's revenue for that year, ₹20 Cr, differs from its quarters added, ₹18 Cr.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue57
  2. Materials and goods−16
  3. Employee costs−7.0
  4. Other expenses−5.1
  5. Operating profit29
  6. Depreciation−3.4
  7. Other income+4.6
  8. One-off items0.0
  9. Finance costs−1.1
  10. Profit before tax29
  11. Net profit22

What the company owns

  • Plant, investments and other assets₹75 Cr
  • Receivables₹23 Cr
  • Inventory₹14 Cr
  • Cash and bank₹6 Cr

What pays for it: net worth and liabilities

  • Net worth₹90 Cr
  • Other liabilities₹12 Cr
  • Owed to suppliers₹10 Cr
  • Borrowings₹5 Cr

Profit and loss

Standalone, ₹ crore, years to March.Shukra Pharmaceuticals quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 4 JunMar 2020Filed 5 AugMar 2021Filed 3 JulMar 2022Filed 9 JunMar 2023Filed 29 MayMar 2024Filed 1 JulMar 2025Filed 13 JunMar 2026Filed 15 Jul
Revenue from operations5.25.45.711.811.220.558.874.632.656.7
3.73.73.910.39.817.653.555.219.928.0
Materials and goods bought1.01.21.23.12.810.345.344.58.115.8
Employee costs1.21.32.04.44.14.94.95.66.17.0
Other expenses1.51.20.82.82.92.43.35.05.65.1
Operating profit before depreciation1.51.61.71.51.42.95.419.412.728.7
Operating margin28.9%30.2%30.7%13.0%12.9%14.1%9.1%26.0%39.1%50.7%
Materials, % of revenue19.0%23.2%21.3%25.9%24.6%50.5%77.0%59.7%24.9%27.9%
Employee costs, % of revenue22.9%23.9%34.4%37.1%36.3%23.9%8.3%7.6%18.7%12.4%
Other expenses, % of revenue29.3%22.7%13.6%23.9%26.2%11.5%5.5%6.8%17.3%9.0%
Depreciation and amortisation0.50.71.01.51.51.71.82.13.03.4
Operating profit after depreciation1.00.90.80.10.01.23.517.49.725.3
Other income0.00.10.00.00.40.11.22.84.24.6
Finance costs0.00.00.00.00.00.30.30.30.61.1
Profit before one-off items and tax1.00.90.80.10.31.04.419.913.328.8
One-off items––0.00.1−0.20.00.00.00.00.0
Profit before tax1.00.90.80.20.11.04.419.913.328.8
0.3−0.10.30.10.10.30.01.33.8–
Net profit0.71.00.50.00.00.84.418.59.622.0
Other comprehensive income––0.00.00.00.00.00.00.0−0.1
Total comprehensive income––0.50.00.00.84.418.59.622.0
Net margin14.0%19.1%8.1%0.3%0.3%3.7%7.5%24.9%29.4%38.9%
Tax is left blank for the year to Mar 2026: profit before tax less the tax charge stated does not come to the profit after tax the same statement states, so the tax charge is not shown.
Earlier years, Mar 2008 to Mar 2016
₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue from operations3.87.39.510.06.75.14.52.64.8
3.36.88.4––––2.73.6
Materials and goods bought2.2–6.46.24.53.53.31.21.7
Employee costs0.7––––––1.11.2
Other expenses0.5––––––0.40.8
Operating profit before depreciation0.50.51.1––––−0.11.2
Operating margin12.3%6.8%11.9%––––−3.5%24.6%
Materials, % of revenue57.7%––––––46.1%34.9%
Employee costs, % of revenue18.3%––––––41.0%24.0%
Other expenses, % of revenue13.1%––––––16.5%16.5%
Depreciation and amortisation0.40.40.50.50.50.70.80.60.4
Operating profit after depreciation0.00.10.7––––−0.70.7
Other income0.10.20.10.1––0.20.60.1
Finance costs0.20.30.6––––0.00.0
Profit before one-off items and tax–0.10.21.2−7.6−3.1−0.7−0.10.8
One-off items–––––––0.3−0.4
Profit before tax−0.10.10.21.2−7.6−3.1−0.70.30.4
Tax0.00.0–––––0.10.2
Net profit−0.10.00.21.2−7.6−3.1−0.70.10.2
Net margin−1.8%0.7%1.9%11.7%−113.3%−59.5%−15.0%4.6%3.5%
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 4 JunMar 2020Filed 5 AugMar 2021Filed 3 JulMar 2022Filed 9 JunMar 2023Filed 29 MayMar 2024Filed 1 JulMar 2025Filed 13 JunMar 2026Filed 15 Jul
1615161625586390
Share capital22224114444
Reserves1414141521471946
681035345
4761243141723
9111367674
Total assets29343435757887117
1719201922482134
1214151653296584
Net debt68931−7−8−1
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 3 JulMar 2022Filed 9 JunMar 2023Filed 29 MayMar 2024Filed 1 JulMar 2025Filed 13 JunMar 2026Filed 15 Jul
0.47.83.2−4.67.93.1
0.48.03.5−4.911.74.8
−1.35.3−3.1−26.0−3.8−26.8
Receivables−1.02.3−22.85.715.7−14.2
Inventories−0.3−2.30.80.8−7.6−4.0
Payables−1.63.326.1−26.22.00.8
Other working capital1.62.0−7.2−6.4−13.9−9.5
Tax paid0.0−0.4−0.30.0−3.8−1.6
Interest paid0.00.0−0.10.30.00.0
Capital spending1.81.64.51.82.70.0
Free cash flow−1.46.2−1.3−6.35.23.1
−1.8−1.5−4.4−1.8−1.3−14.2
1.7−6.74.912.4−4.54.8
Dividends paid0.00.00.10.14.40.4
Shares bought back0.00.00.00.00.00.0
Shares issued0.00.04.613.90.00.0
Net change in cash0.3−0.43.76.02.1−6.2
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.Shukra Pharmaceuticals dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 4 JunMar 2020Filed 5 AugMar 2021Filed 3 JulMar 2022Filed 9 JunMar 2023Filed 29 MayMar 2024Filed 1 JulMar 2025Filed 13 JunMar 2026Filed 15 Jul
––––––––₹0.22₹0.50
As stated that year₹0.46–₹2.96₹0.23₹0.22₹4.79₹26.21₹16.93₹0.22₹0.50
––––––––₹0.22₹0.50
Dividend per share–––––––––₹0.01
––––––––₹1.44₹2.05
Dividend payout–––––––––2.0%
Shareholder yield––––0.0%0.0%−8.9%−3.9%0.5%0.0%
Market cap at the year end (₹ crore)12106779513579571,329
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from. As stated that year and earnings per share are left blank for the year to Mar 2018: the earnings per share stated does not match any profit the filing states over the shares in issue, and the share count barely moved during the period.
RatioMar 2017Mar 2018Mar 2019Filed 4 JunMar 2020Filed 5 AugMar 2021Filed 3 JulMar 2022Filed 9 JunMar 2023Filed 29 MayMar 2024Filed 1 JulMar 2025Filed 13 JunMar 2026Filed 15 Jul
Revenue growth7.2%3.7%6.1%–−5.5%–187.2%26.8%−56.3%74.0%
Operating profit growth25.6%8.3%8.1%–−6.3%–85.9%261.8%−34.4%125.6%
Net profit growth328.4%41.3%−54.8%−92.3%−5.1%2,121.0%487.0%320.7%−48.3%130.3%
Earnings per share growth–––––––––127.3%
––3.0%0.2%0.2%4.7%21.2%44.7%15.9%28.9%
–––−2.7 pts0.0 pts4.5 pts16.5 pts23.5 pts−28.8 pts13.0 pts
From the net margin–––−2.9 pts0.0 pts2.4 pts4.9 pts49.1 pts8.1 pts5.1 pts
From asset turnover–––0.1 pts0.0 pts2.1 pts7.8 pts−6.1 pts−31.4 pts8.5 pts
From borrowing–––0.0 pts0.0 pts0.0 pts3.8 pts−19.4 pts−5.5 pts−0.6 pts
Return on capital employed––3.6%0.3%−0.1%6.2%11.6%28.5%14.5%26.7%
Cash conversion––––1,099.1%1,036.9%71.9%−24.7%82.7%14.3%
Interest cover177.219.31,308.829.6–4.312.660.916.323.1
Debt to equity––0.410.520.630.210.200.050.070.06
Receivable days––338245290132187098148
Inventory days––82157225139250448320
Payable days––1,14876664230327659415232
Cash conversion cycle, days––−729−364−127−32−63−59131236
Working capital days––474226277624928415364
Asset turnover––0.190.380.330.591.070.980.400.56
Assets per rupee of net worth––1.892.032.182.172.641.841.371.34
Sales per rupee of plant––0.370.680.631.172.913.741.682.61
Capital spending to depreciation––––1.230.932.440.860.910.00
Plant being built, % of plant in use––11.0%9.6%9.4%9.5%8.2%8.3%10.0%54.8%
Revenue growth and operating profit growth are left blank for the years to Mar 2020 and Mar 2022: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. Interest cover is left blank for the year to Mar 2021: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
21.6%
Cash from operations against operating profit
11.0%
Measure10 years5 years3 years
Revenue growth, yearly rate27.9%38.3%−1.2%
Profit growth, yearly rate62.8%265.5%71.0%
Return on equity, average–23.1%29.8%
Return on capital employed, average–17.5%23.2%
Operating margin, average25.5%27.8%38.6%
Net margin, average14.6%20.9%31.0%
Asset turnover, average–0.720.64
Cash conversion cycle, days, average–43103
Interest cover, average183.623.433.5
Debt to equity, average–0.120.06

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations17.46.53.1
Cash from investing−23.2−17.3−14.2
Cash from financing11.012.74.8
Capital spending10.54.50.0
Dividends paid5.04.90.4
Shares bought back0.00.00.0
Shares issued for cash18.513.90.0
Borrowings raised––0.8
Borrowings repaid0.00.00.0

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––675546
Altman Z-scorePublished threshold 1.81––1.51–1.451.712.1813.5125.86–
Beneish M-scorePublished threshold −1.78––––−2.43−2.800.004.44–0.93
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––4.34−15.9010.2932.643.5532.40
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––2.180.270.200.13
Receivables growth less revenue growthOur threshold 0 percentage points–––−57.1917.46−99.85120.66−126.75–87.74
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––234.0438.91−142.54−358.20−98.17–−55.69
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––34.13−13.08−12.0321.025.3221.2225.38
Assets under construction, years of additionsOur threshold 2 years of additions–––0.500.931.070.370.940.792.06
Effective tax ratePublished threshold 17.16 per cent30.78−8.1441.4279.1665.4426.260.796.7728.20–
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––−16.67−4.846.770.00–
A threshold marked as ours has no published figure; it is the line we read the check against.